GO
Loading...

RESEARCH ALERT-Lazard raises Vertex Pharmaceuticals price target

Oct 2 (Reuters) - Vertex Pharmaceuticals Inc :

* Lazard raises Vertex Pharmaceuticals Inc price target to $75 from

$57; rating buy

For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Equities Newsdesk +91 80 4135 5800; within U.S. +1 646 223 8780))

((Bangalore Equities Newsdesk +91 80 4135 5800; within U.S. +1 646 223 8780))